Key Highlights

  • Quantum Cyber (NASDAQ:QUCY) traded at USD 0.9691, up 13.81%, in pre-market trading on Tuesday, October 27, 2026, after a release of Monday, October 26, 2026 on a quantum antenna presentation. The company stated that it was not a funded award.
  • AmpliTech Group (NASDAQ:AMPG) traded at USD 2.77, up 5.73%, following a record USD 21.7 million 5G radio order announced on Tuesday, October 20, 2026. No announcement dated October 27 was identified.
  • Onconetix (NASDAQ:ONCO) traded at USD 0.3455, down 13.43%, after announcing a 1-for-10 reverse stock split on Monday, October 26, 2026. The latest quarterly filing states substantial doubt about going concern.
  • Nauticus Robotics (NASDAQ:KITT) traded at USD 1.23, down 6.11%, with no company-specific announcement. Cash, cash equivalents and restricted cash were USD 1,977,049 at June 30, 2026. All four quotes are thin snapshots and can change before the open at 9:30 a.m. ET.

Quantum Cyber (NASDAQ:QUCY): a presentation, a facility and no contract

Quantum Cyber N.V. (NASDAQ:QUCY), an autonomous defence technology company that is building drone, quantum antenna and swarm software platforms, implies a prior close of about USD 0.85 by simple arithmetic. The release of Monday, October 26, 2026 stated that the company was invited to present its quantum antenna technology at a quantum sensing convening on Friday, October 16, 2026. On Friday, September 25, 2026 the company narrowed its focus to one-way attack drones and interceptors, the quantum antenna licensed under an agreement of Thursday, June 11, 2026 and the MAHCA swarm software. It acquired its Bridgeport, Connecticut facility and business for USD 4.18 million in cash on Thursday, July 16, 2026.

An 80-unit 3D printing drone production farm at the Bridgeport facility became operational on Monday, August 31, 2026. The target of 100,000 drones a year is a management projection and not current capacity. No revenue, net loss or cash figures were included in these releases, so the mechanism is narrative momentum in a thinly traded share. The bull reading is that defence procurement interest in autonomous systems could convert the facility and licence into contracts. The bear reading is that the request for information of Friday, September 4, 2026 is a solicitation and not an order. Named risks include dilution and execution risk. The filing of Monday, September 28, 2026 carried audited Arcade statements without a going-concern qualification.

AmpliTech (NASDAQ:AMPG): an order book ahead of reported revenue

AmpliTech Group (NASDAQ:AMPG), a designer of radio-frequency components, satellite communications equipment and Open RAN 5G radios, announced a record follow-on purchase order for 5G O-RAN radios from an Asian mobile network operator on Tuesday, October 20, 2026. That release states cumulative orders of about USD 34 million under a related USD 78 million letter of intent programme, and the release of Wednesday, October 21, 2026 states total backlog above USD 52 million. Purchase orders above USD 17 million in the third quarter were reported on Wednesday, October 14, 2026. The rise appears consistent with a delayed reaction to these orders and thin pre-market liquidity.

The latest results are those of Thursday, August 13, 2026 for the quarter ended June 30, 2026. Revenue was USD 8.07 million, gross margin was 27.9% against 7.8% a year earlier and the net loss was USD 3.09 million. Cash, equivalents and marketable securities were USD 12.95 million, and the company believes existing cash can fund operations through fiscal 2027, on its own estimate. Order announcements are not revenue, and the quarter ended September 30, 2026 has not yet been reported. Named risks are customer concentration, delivery timing and dilution from past financings, including a Series A rights offering with USD 21.92 million in gross proceeds.

Onconetix (NASDAQ:ONCO): a reverse split and a share exchange

Onconetix (NASDAQ:ONCO), a commercial-stage oncology company that owns the Swiss prostate cancer diagnostics business Proteomedix, announced board approval of a 1-for-10 reverse stock split, expected to take effect on Friday, November 6, 2026. It would cut common shares from about 5,886,774 to about 588,677. A reverse split consolidates shares to raise the quoted price without changing the value of each holder's stake, and the decline appears consistent with the usual market reaction to such actions, which is an inference. The release of Friday, October 23, 2026 added USD 500,000 of bridge financing to Realbotix LLC, bringing principal outstanding to USD 3,000,000 under a facility of up to USD 5,000,000.

The Form 10-Q for the quarter ended June 30, 2026 reported revenue of USD 17,120, against USD 106,494 a year earlier, and a net loss of USD 2,867,303, or USD 1.28 per share. Cash was about USD 5.9 million at June 30, 2026. The company holds a share exchange agreement to acquire all equity of Realbotix LLC for stock, subject to shareholder and regulatory approvals. Realbotix Corp reported third quarter revenue of USD 354,000, against USD 595,000, and expects closing in the fourth quarter. The bull reading is a humanoid robotics operation replacing a diagnostics business. Risks are dilution through preferred stock, a failed shareholder vote and interest of 12% a year on the bridge if the agreement terminates.

Nauticus Robotics (NASDAQ:KITT): defence scope against thin cash

Nauticus Robotics (NASDAQ:KITT), a Houston-based developer of autonomous subsea robots and related software, had no company-specific announcement dated on or just before the session. The decline appears consistent with thin liquidity and with micro-cap stocks that fund operations through share issuance, an inference. The earnings release of Wednesday, August 12, 2026 reported revenue of USD 885,947 for the quarter ended June 30, 2026, against USD 2,075,566 in the prior-year quarter. The operating loss was USD 6,008,392, and the net loss was USD 11,115,972, or USD 2.30 per share, including a loss on extinguishment of debt of USD 4,629,822.

Fundamental updates included the commercial release of the ToolKITT tool and a completed first scope of work in a multiphase defence opportunity, which the company said could bring revenue in 2026 and 2027. The release gave no numeric guidance or backlog figure. Financing during 2026 included at-the-market share sales and debenture proceeds, and a 1-for-8 reverse split took effect on Tuesday, April 21, 2026, after a 1-for-9 split in 2025. The bear reading is that cash implies further funding, since the quarterly operating loss is about three times the cash balance, by simple arithmetic. Named risks are dilution, listing pressure after two reverse splits and revenue concentration in a small number of offshore projects.

Where Things Stand

The answer is that contracts can outweigh cash needs only where orders already exist and funding looks adequate, which describes AmpliTech (NASDAQ:AMPG) more than the others. Quantum Cyber (NASDAQ:QUCY) rose on a presentation with no contract. Onconetix (NASDAQ:ONCO) fell as a reverse split and a going concern warning outweighed a pending share exchange. Nauticus Robotics (NASDAQ:KITT) holds a defence scope of work but little cash.

The next catalysts are the Federal Reserve decision on Wednesday, October 28, 2026, which follows the rate rise to 4.00% from 3.75% on Wednesday, September 16, 2026, the Onconetix split on Friday, November 6, 2026, the AmpliTech third quarter results and any defence award. Pre-market prices are thinly traded and can change, and this is not investment advice.